TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year PAT Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
PAT Growth(%) | -1.31 | 52.46 | - |
What is the latest PAT Growth ratio of TRIDENT LIFELINE ?
Year | PAT Growth |
---|---|
Mar2024 | -1.31 |
Mar2023 | 52.46 |
Mar2022 | - |
How is PAT Growth of TRIDENT LIFELINE Trending?
Years | PAT Growth | % Change | |
---|---|---|---|
Mar2024 | -1.31 | Negative | |
Mar2023 | 52.46 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare PAT Growth ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹325.7 Cr | -0.1% | 2.8% | 49.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -0.1% |
2.8% |
49.3% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses